Haemonetics Corp. (HAE)
70.22
+0.11
(+0.16%)
USD |
NYSE |
Jan 22, 14:02
Haemonetics Market Cap: 3.287B for Jan. 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 189.47B |
| Solventum Corp. | 13.96B |
| DexCom, Inc. | 29.14B |
| Masimo Corp. | 7.687B |
| UFP Technologies, Inc. | 2.085B |
Market Cap Related Metrics
| PE Ratio | 20.49 |
| PS Ratio | 2.593 |
| PEG Ratio | 0.4837 |
| Price to Book Value | 3.871 |
| Price to Free Cash Flow | 13.45 |
| Price | 70.22 |
| Earnings Yield | 4.88% |
| PEGY Ratio | 0.4837 |
| Operating PE Ratio | 14.56 |
| Normalized PE Ratio | 20.45 |